Kirin Brewery Co.,LTD Company Profile

07:57 EDT 22nd March 2018 | BioPortfolio



2-10-1 Shinkawa


Phone: 03(5540)3411
Fax: 03(5540)3547

News Articles [64 Associated News Articles listed on BioPortfolio]

Kirin-Amgen JV To Become Wholly-owned Subsidiary Of Amgen

THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) said that the company and Kirin Holdings (KNBWF.PK, KNBWY.PK) have agreed that Kirin-Amgen, a joint venture between the two companies, will redeem Kirin...

Kirin-Amgen Joint Venture To Become Wholly-Owned Subsidiary Of Amgen

$780 Million Payment to be Funded From Joint Venture's Existing Cash Holdings Kyowa Hakko Kirin to Continue as Licensee in Asia THOUSAND OAKS, Calif., Oct. 30, 2017 /PRNewswire/ -- Amgen (NASDAQ:AM...

Kyowa Kirin und Ultragenyx geben bekannt, dass Crysvita® (Burosumab) eine bedingte Zulassung ...

Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) und Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx) gaben Read more...

Kyowa Hakko Kirin Announces Marketing Authorisation Application for Mogamulizumab Validated by ...

Kyowa Hakko Kirin Co. Ltd.MediaHiroki Nakamura,

Ultragenyx und Kyowa Kirin geben bekannt, dass Burosumab eine positive Stellungnahme des CHMP zur Behandlung der X-chromosomalen Hypophosphatämie bei Kindern erhalten hat

Tokio, London, und Novato, Kalifornien (ots/PRNewswire) - Bei Zulassung wäre Burosumab die erste gezielte krankheitsmodifizierende Behandlung für XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin)....

Kirin Cashes Out of Amgen Drug Joint Venture for $780M

Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen.

Kyowa Hakko Kirin gibt von der Europäischen Arzneimittelagentur verifizierten Vermarktungszulassungsantrag für Mogamulizumab bekannt

Tokio (ots/PRNewswire) - Die Kyowa Hakko Kirin Co., Ltd. (Tokio: 4151 President und CEO: Nobuo Hanai, "Kyowa Hakko Kirin" gibt heute bekannt, dass ihr Vermarktungszulassungsantrag (MAA) für Mogamul.....

Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review Designation of Mogamulizumab Biologics License Application

TOKYO--(BUSINESS WIRE)-- November 28, 2017 Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151) (President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announces that the U.S. Food and Drug Administration...

Drugs and Medications [0 Results]


PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Balancing carbon/nitrogen ratio to improve nutrients removal and algal biomass production in piggery and brewery wastewaters.

To improve nutrients removal from wastewaters and enhance algal biomass production, piggery wastewater was mixed with brewery wastewaters. The results showed that it was a promising way to cultivate m...

Anaerobic digestion of Brewery Spent Grains: Trace elements addition requirement.

The current study evaluates and compares the stability of anaerobic digestion of Brewery Spent Grains (BSG) with and without addition of nutrients. Based on the composition of the BSG two levels of nu...

Combining biotechnology with circular bioeconomy: From poultry, swine, cattle, brewery, dairy and urban wastewaters to biohydrogen.

The ability of microalgae to grow in nutrient-rich environments and to accumulate nutrients from wastewaters (WW) makes them attractive for the sustainable and low-cost treatment of WW. The valuable b...

Chromosomal aneuploidy improves brewing characteristics of sake yeast.

The effect of chromosomal aneuploidy on the brewing characteristics in brewery yeasts has not been studied. Here, we report that chromosomal aneuploidy in sake brewery yeast (Saccharomyces cerevisiae)...

Resveratrol suppresses ethanol stress in winery and bottom brewery yeast by affecting superoxide dismutase, lipid peroxidation and fatty acid profile.

Mid-exponential cultures of two traditional biotechnological yeast species, winery Saccharomyces cerevisiae and the less ethanol tolerant bottom-fermenting brewery Saccharomyces pastorianus, were expo...

Clinical Trials [0 Results]


Companies [16 Associated Companies listed on BioPortfolio]

Kirin Brewery Co.,LTD


Kirin Brewery Company Limited

Drug Discovery

Hematech, Inc.

Hematech, LLC was founded in 1998 and has its corporate headquarters in Sioux Falls, SD. In 1999, Hematech and the Pharmaceutical Division of the Kirin Brewery Company began a research collaboration t...

Kyowa Hakko Kirin Co., Ltd.

Kyowa Hakko Kirin Co. Ltd.

More Information about "Kirin Brewery Co.,LTD" on BioPortfolio

We have published hundreds of Kirin Brewery Co.,LTD news stories on BioPortfolio along with dozens of Kirin Brewery Co.,LTD Clinical Trials and PubMed Articles about Kirin Brewery Co.,LTD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kirin Brewery Co.,LTD Companies in our database. You can also find out about relevant Kirin Brewery Co.,LTD Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record